Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34086865

Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2021 Nov 11
First author
Cramer P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Nov 11;138(19):1785-1786. doi: 10.1182/blood.2021012759.
    note
    Source null
    related pmid
    34762129
    relationship
    Comment in

Authors and identifiers

  1. name
    Cramer P
    type
    Author
  2. name
    Tausch E
    type
    Author
  3. name
    von Tresckow J
    type
    Author
  4. name
    Giza A
    type
    Author
  5. name
    Robrecht S
    type
    Author
  6. name
    Schneider C
    type
    Author
  7. name
    Fürstenau M
    type
    Author
  8. name
    Langerbeins P
    type
    Author
  9. name
    Al-Sawaf O
    type
    Author
  10. name
    Pelzer BW
    type
    Author
  11. name
    Fink AM
    type
    Author
  12. name
    Fischer K
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cramer P
    type
    Author
  2. name
    Tausch E
    type
    Author
  3. name
    von Tresckow J
    type
    Author
  4. name
    Giza A
    type
    Author
  5. name
    Robrecht S
    type
    Author
  6. name
    Schneider C
    type
    Author
  7. name
    Fürstenau M
    type
    Author
  8. name
    Langerbeins P
    type
    Author
  9. name
    Al-Sawaf O
    type
    Author
  10. name
    Pelzer BW
    type
    Author
  11. name
    Fink AM
    type
    Author
  12. name
    Fischer K
    type
    Author
bibliography ids
  1. nci-bib-1070f9394732ec8b5f797ea9
book metadata
content sha256
7ab40557d5d12183027bb5ca67769c978ce8326bc42e992a1d800ae1174d1b78
document type
citation
dois
  1. 10.1182/blood.2020010484
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:34086865
immutable id
pubmed:34086865@7ab40557d5d12183027bb5ca67769c978ce8326bc42e992a1d800ae1174d1b78
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
19
name
Blood
nlm unique id
7603509
pages
1805-1816
volume
138
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Nov 11;138(19):1785-1786. doi: 10.1182/blood.2021012759.
    note
    Source null
    related pmid
    34762129
    relationship
    Comment in
outcomes validated
false
pmid
34086865
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
bd50b055f2a1c0651f1982d42d465f051f6d1258705a2a08c8e6962d7589e3ad
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Nov 11
precision
day
year
2021
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34086865/
title
Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations.

Preserved source evidence · Not medical advice